Background/Aims: Antimicrobial peptides are effective promoters of wound healing but are susceptible to degradation. In this study, we replaced the GIGDP unit on the N-terminal of the endogenous human antimicrobial peptide hBD-2 with APKAM to produce A-hBD-2 and analyzed the effect on wound healing both in vitro and in vivo. Methods: The effects of A-hBD-2 and hBD-2 on cytotoxicity and proliferation in keratinocytes were assessed by Cell Counting Kit-8 assay. The structural stability and antimicrobial activity of hBD-2 and A-hBD-2 were evaluated against Staphylococcus aureus. RNA and proteins levels were evaluated by real-time PCR and western blotting, respectively. Cell migration was evaluated using a transwell assay. Cell cycle analysis was performed by flow cytometry. Wound healing was assessed in SpragueDawley rats. Epidermal thickness was evaluated by hematoxylin and eosin staining. Results: We found that hBD-2 exhibited cytotoxicity at high concentrations and decreased the structural stability in the presence of high sodium chloride concentrations. A-hBD-2 exhibited increased structural stability and antimicrobial activity, and had lower cytotoxicity in keratinocytes. A-hBD-2 increased the migration and proliferation of keratinocytes via phosphorylation of EGFR and STAT3 and suppressed terminal differentiation of keratinocytes. We also found that A-hBD-2 elicited mobilization of intracellular Ca 2+ and stimulated keratinocytes to produce pro-and anti-inflammatory cytokines and chemokines via phospholipase C activation. Furthermore, A-hBD-2 promoted wound healing in vivo. Conclusion: Our data suggest that A-hBD-2 may be a promising candidate therapy for wound healing.
Peptides and enzymes
The synthetic peptides hBD-2 (GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP) and A-hBD-2 (APKAMVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP) were synthesized by Mimotopes PTY Ltd. (Wuxi, China). Synthesized peptides were purified to over 95% by reversed-phase high-pressure liquid chromatography (30 μm × 25 μm, Beijing ChuangXinTongHeng Science and Technology Co., Ltd., Beijing, China). The peptide content of lyophilized samples was determined by quantitative amino acid analysis on a LC 3000 amino acid analyzer (4.6 mm×250 mm, Beijing ChuangXinTongHeng Science and Technology Co., Ltd.). The analysis results for hBD-2 and A-hBD-2 can be found in Fig. S1 (For all supplemental material see www.karger.com/10.1159/000495320).
Isolation and culture of human keratinocytes
Normal skin was obtained from patients who underwent plastic surgery with appropriate approval from the Wuhan Union Hospital Committee on Human Research. Skin tissue was incubated overnight at 37°C in keratinocyte selection medium (epidermal keratinocyte medium CnT07, low Ca 2+ , CELLnTEC, Bern, Switzerland) with Dispase II (Roche). The epidermis was separated from the dermis using two pairs of forceps. The epidermis was cut into pieces and incubated in trypsin for 30 min at 37°C. Freshly isolated cells were washed with medium and incubated with CnT07 selection medium at 37°C in a humidified atmosphere containing 5% CO 2 . The medium was changed every 2-3 days. Cell passages 2-3 were used for the experiments.
Cytotoxicity and proliferation assay in vitro
To analyze the effect of hBD-2 and A-hBD-2 on cytotoxicity and proliferation, HaCaT cells were cultured in 96-well plates (10 4 cells/well) in DMEM with 10% FBS for 24 h. For the cytotoxicity assay, cells were incubated with various concentration of hBD-2 or A-hBD-2 for 24 h, 48 h, or 72 h. For the proliferation assay, cells were incubated with hBD-2, A-hBD-2, A-hBD-2 + AG1478, or A-hBD-2 + S3I-201 for 24 h, 48 h, or 72 h. Thereafter, cells were treated with Cell Counting Kit-8 (CCK8; MedChemExpress, Monmouth Junction, NJ, USA) reagent and cultured for 2 h. Absorbance was detected at 450 nm. For the cytotoxicity assay, data were collected and compared with certain concentrations of peptides and 0 μg/mL peptides. For the proliferation assay, data were collected and compared between the experimental and control groups.
Salt resistance assay and antimicrobial activity assay
The structural stability and antimicrobial activity assay of hBD-2 and A-hBD-2 were determined against Staphylococcus aureus in various concentrations of sodium chloride (NaCl) solution. Briefly, S. aureus was cultured at 37°C in lysogeny broth (LB) medium. Bacteria were sub-cultured at 1:300, grown to mid-log phase, and harvested by centrifugation at 600 × g. After washing the pellets, approximately 1 × Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry Table 1 . Primer sequences of RT-PCR. Note:qRT-PCR:quantitative realtime polymerase chain reaction; IL-6:interleukin 6;TNF-α: tumor necrosis factor alpha;IL-10: interleukin 10;MCP-1:monocyte chemoattractant protein-1; F: forward;R:reverse 10 6 colony forming units (CFU)/mL was diluted in 1% lysogeny broth-sodium phosphate buffer. Dried hBD-2 and A-hBD-2 were then mixed with the above suspension and incubated for 3 h at 37°C. Subsequently, 10 μL of the mixture was extracted and the reaction was stopped by a 1000-fold dilution with distilled water. Various concentrations of NaCl were added and aliquots were manually spread on LB agar plates. After 24 h at 37°C the colonies were counted and the percentiles of inhibition were calculated. Three single experiments were carried out.
Cell cycle assay
Cell cycle progression was detected with propidium iodide (Sigma-Aldrich, MO) staining using a flow cytometer. Briefly, cells were seeded in 6-well culture plates and treated with vehicle, 20 μg/mL hBD-2, 20 μg/mL A-hBD-2, 20 μg/mL A-hBD-2 and 50 nm AG1478, or 20 μg/mL A-hBD-2 and 50 μM S3I-201. After incubation for 48 h, cells were fixed with 70% cold ethanol at 4°C overnight. The cells were then rehydrated, washed twice with ice-cold phosphate-buffered saline (PBS), and incubated with 10 μL RNase at 37°C for 30 min. The cell cycle was analyzed by fluorescence-activated cell sorting on a flow cytometer (FACS Calibur, Becton Dickinson, San Jose, CA).
Cell migration assay
Cell migration was measured using a transwell chamber (8-μm pore size; Costar, Corning, NY). Cells in serum-free media were placed in the upper chamber and media containing 10% FBS was added to the lower chamber. Then, the vehicle, 20 μg/mL hBD-2, 20 μg/mL A-hBD-2, 20 μg/mL A-hBD-2 and 50 nm AG1478, or 20 μg/mL A-hBD-2 and 50 μM S3I-201 were added into the lower chamber. After 48 h incubation, the migrated cells were counted under a microscope.
Western blot analysis
HaCaT cells were treated with vehicle, 20μg/mL hBD-2, 20 μg/mL A-hBD-2, and 20 μg/mL A-hBD-2 and 50 nm AG1478 or 20 μg/mL A-hBD-2 and 50 μM S3I-201 for 20 min (EGFR, p-EGFR, STAT3, p-STAT3) or for 48 h (cyclin D1, cyclin D3, KRT1, KRT5, KRT10, KRT14), and total protein was extracted with RIPA lysis buffer containing 1% phenylmethanesulfonyl fluoride and 1% protease inhibitor cocktail. Equal amounts of total proteins were separated on an 8-10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis run at 80-120 V for 1-2 h, and proteins on the gel were transferred onto a polyvinylidene fluoride membrane (300 mA, 60-90 min). The membrane was incubated with the primary antibodies at 4°C overnight. The membrane was then incubated for 30 min with secondary antibodies at room temperature. Band visualization was conducted with an ECL Advance Western Blotting Detection Kit. Densities were calculated by the Quantity One Software (Canon, Melville, NY) and normalized by GADPH (1:10000, Abcam, #ab37168). The following antibodies were used: cyclin D1 (1:3000, Abcam, #ab134175), cyclin D3 ( 
Real-time PCR
HaCaT cells were treated with vehicle, 20 μg/mL hBD-2, 20 μg/ml A-hBD-2, 20 μg/mL A-hBD-2 and 50 nm AG1478, or 20 μg/mL A-hBD-2 and 50 μM S3I-201 for 6 h, and total RNA was extracted using the Trizol one-step method according to the manufacturer's guidelines (Invitrogen Inc., Carlsbad CA). Reverse transcription of the RNA was performed with PrimeScript™ RT reagent Kit with gDNA Eraser (TaKaRa Bio Inc., Kusatsu, Japan). qRT-PCR was carried out using SYBR® Premix Ex Taq™ (TaKaRa Bio). The primer sequences are shown in 
ELISA
After HaCaT cells were treated with vehicle, 20 μg/mL hBD-2, 20 μg/mL A-hBD-2, and 20 μg/mL A-hBD-2 and 50 nm AG1478 or 20 μg/mL A-hBD-2 and 50 μM S3I-201 for 48 h, the levels of IL-6, IL-10, TNF-α, and MCP-1 in the cell supernatants were measured using an ELISA kit. All analyses and calibrations were performed in duplicate. Optical densities were determined using an absorbance microplate reader at 450 nm (Elx808 TM Bio-TeK Instruments Inc., Winooski, VT).
Measurement of intracellular Ca
2+ concentration HaCaT cells were detached from culture plates using 0.25% trypsin, washed twice with PBS containing 0.2% bovine serum albumin, 0.1% glucose, and 30 μM CaCl 2 , and resuspended in the same buffer at a density of 2 × 10 6 cells/mL. After loading with 4 μM Fura-2AM (Beyotime Biotechnology, Shanghai, China) for 1 h at 37°C, cells were washed three times and resuspended in washing buffer. Fura-2-AM-loaded cells were stimulated with medium containing 0.01% acetic acid, 20 μg/mL hBD-2 or 20 μg/mL A-hBD-2 (0-200 s), and fluorescence was measured at 340 nm excitation and 510 nm emission, using an EnSpire spectrofluorometer (PerkinElmer, Inc., Waltham, MA).
Animal experiments
A total of 15 male Sprague-Dawley rats (age 4-6 weeks) were purchased from The Center of Experimental Animal, Tongji Medical College, Huazhong University of Science and Technology. The rats were anesthetized using 10% chloral hydrate (0.3 mL/100 g body weight). One full-thickness dorsal wound was created on each rat. The rats were randomly divided into three groups: control group, hBD-2 group, and A-hBD-2 group. PBS (1 mL) and 20 μg/mL hBD-2 or 20 μg/mL A-hBD-2 were applied directly to each wound via a small dropper. The wounds were covered with transparent dressings (Tegaderm TM Film) to prevent the loss of PBS and hBD-2 or A-hBD-2. All rats were kept on a 12-h light-dark cycle with free access to food and water. The protocol was approved by the Institutional Animal Care and Use Committee at Tongji Medical College, Huazhong University of Science and Technology. After 10 days, the rats were sacrificed, and the central tissue of the wound was harvested for hematoxylin and eosin (H&E) staining.
Photography and wound area measurement
The wound was monitored by taking digital photographs on days 0, 3, 5, 7, and 10. Wound areas were calculated from the photographs with Image-Pro Plus (version 6.0, Media Cybernetics, Inc., Rockville, MD; n = 5/group). The wound closure rate was calculated as a percentage using the following formula:
Wound closure rate (%) = (wound area on day zero -wound area on a particular day)/wound area on day zero × 100
H&E staining
Tissues were fixed overnight in 4% (wt/vol) paraformaldehyde in PBS, embedded in paraffin, and sliced into 4-μm sections. The sections were deparaffinized in three changes of xylene and rehydrated through a graded series of ethanol. The sections were stained with hematoxylin for 5 min and eosin for 1 min. The H&E-stained slides were photographed using a microscope at 200x (IX51, Olympus, Tokyo, Japan). The epidermal thickness was evaluated in three fields of each sample. Three independent observers blinded to the experiments completed these analyses and a mean value of each measurement was taken for statistical analysis.
Statistical analysis
Statistical analyses were conducted using GraphPad Prism 6.0 (GraphPad Software, Inc, La Jolla, CA). Results are presented as the mean ± standard deviation (SD). Statistically significant differences were determined using one-way analysis of variance test or the Student's t test. A value of P < 0.05 was considered statistically significant.
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Results
Cytotoxicity of A-hBD-2 on keratinocytes
Previous studies have shown that high concentrations of hBD-2 have cytotoxic effects in cells. In this study, we assessed the cytotoxicity of hBD-2 and A-hBD-2 on HaCaT cells with CCK8. Our results showed that hBD-2 exhibited significant cytotoxic effects on HaCaT cells at concentrations of 70 μg/mL and 100 μg/mL after 24 h, 48 h, and 72 h of incubation, and 50 μg/mL hBD-2 showed cytotoxic effects in HaCaT cell after 72 h. However, various concentrations (0-100 μg/mL) of A-hBD-2 showed no cytotoxicity in HaCaT cells, although 100 μg/mL A-hBD-2 showed no significant difference compared with 0 μg/mL A-hBD-2 at 72 h. In addition, 20 μg/mL hBD-2 and 30 μg/mL A-hBD-2 showed the lowest cytotoxic effects in HaCaT cells (Fig. 2) .
Antimicrobial activity and structural stability Our study found that at peptide concentrations of 0 and 30 μg/mL hBD-2 and A-hBD-2 had similar anti-S. aureus activity. However, A-hBD-2 had higher anti-S. aureus activity than did hBD-2 at concentrations of 50 μg/mL, 70 μg/mL, and 100 μg/mL (Fig. 3a) . Both hBD-2 and A-hBD-2 exhibited the greatest anti-S. aureus activity in the absence of NaCl. At concentrations of 50 mM, 70 mM, and 100 mM NaCl, A-hBD-2 showed higher anti-S. aureus activity than did hBD-2. hBD-2 and A-hBD-2 exhibited similar anti-S. aureus activity in the presence of 150 mM NaCl (Fig. 3b) .
A-hBD-2 increased the proliferation and stimulated the migration keratinocytes
The effects of hBD-2 and A-hBD-2 on the proliferation of HaCaT cells are illustrated in Fig. 4 . Following the incubation of HaCaT cells with 20 μg /mL hBD-2, 20 μg /mL A-hBD-2, or vehicle (control), the hBD-2 and A-hBD-2 groups showed greater cell viability compared with the control group (Fig. 4a) . Furthermore, a greater number of HaCaT cells reached the S phase ( Fig. 4d and 4e) . Proteins related to proliferation (cyclin D1 and cyclin D3 in Fig. 4b and 5c, respectively) were increased in the hBD-2 and A-hBD-2 groups compared with the control group. In the cell migration assay, hBD-2 and A-hBD-2 groups also showed higher cell numbers compared with the control group. There was no significant difference between the hBD-2 and A-hBD-2 groups in terms of promoting HaCaT cell migration (Fig. 5) . We further verified the effect of hBD-2 or A-hBD-2 on freshly isolated human keratinocytes. Our results suggested that both hBD-2 and A-hBD-2 have a positive effect on their proliferation and migration (Fig. 6) . , and 72 h (c). CCK8 assay was then performed to evaluate cytotoxicity, which was reflected in cell numbers. All experiments were performed in triplicate. Statistical analysis was performed for various concentrations of peptides to 0 μg/ mL peptides. Data are expressed as the mean ± SD. In the cell and animal experiments, 20 μg/mL hBD-2 and 20 μg/mL A-hBD-2 were used. *P<0.05, **P<0.01, ***P<0.001. 
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A-hBD-2 induced keratinocytes proliferation and migration by phosphorylation of EGFR and STAT3
Previous studies have reported that EGFR and STAT3 are phosphorylated by hBD-2 and involved in the processes of migration and proliferation in keratinocytes [14, 15] . In this study, we investigated whether A-hBD-2 induces the phosphorylation of EGFR and STAT3 in HaCaT cells. EGFR and STAT3 were phosphorylated 20 min after the addition of hBD-2 (20 μg/mL) or A-hBD-2 (20 μg/mL) in HaCaT cells (Fig. 7) . The A-hBD-2 group showed a higher rate of EGFR and STAT3 phosphorylation compared with the control group. To further confirm our conclusion that the phosphorylation of EGFR and STAT3 is required for migration and proliferation of keratinocytes, HaCaT cells were pretreated with 50 nM anti-EGFR inhibitor (AG1478) or 50 μM anti-STAT3 (S3I-201), and proliferation and migration assays were performed. AG1478 and S3I-201 were markedly reduced and A-hBD-2 mediated the proliferation and migration of keratinocytes (Fig. 4b-4e, 5a , and 5b). These observations implied that the activation of EGFR and STAT3 is necessary for A-hBD-2 mediated migration and proliferation of keratinocytes.
A-hBD-2 induced keratinocyte proliferation via the inhibition of differentiation
To investigate the effects of A-hBD-2 on keratinocyte proliferation and differentiation, the expression of KRT 5 and KRT 14 proteins, which are associated with keratinocyte proliferation, and KRT 1 and KRT 10, which are related to keratinocyte differentiation, were assessed. Our data indicated that the epidermal basal layer marker KRT 5 and KRT 14, but not the differentiation markers KRT 1 and KRT 10, were significantly increased following stimulation with hBD-2 or A-hBD-2 ( Fig. 8a and 8b ) compared with the control group (vehicle). To further demonstrate that hBD-2 or A-hBD-2 inhibits keratinocyte differentiation, we measured the levels of loricrin and filaggrin because they are increased in the terminal differentiation of keratinocytes. The expression levels of Ioricrin and filaggrin were suppressed after stimulation with hBD-2 or A-hBD-2 compared with the control group (Fig. 8c) .
A-hBD-2 elicited keratinocytes intracellular Ca
2+ mobilization Previous studies have shown that AMPs, including hBD-2, induce rapid Ca 2+ flux across the plasma membrane, elevating Ca 2+ concentrations in keratinocytes. Such Ca 2+ influx has been linked to the migration and proliferation of keratinocytes. Therefore, we examined the ability of A-hBD-2 to mobilize intracellular Ca 2+ in keratinocytes. We observed that hBD-2 and A-hBD-2 markedly elevated the concentrations of intracellular Ca 2+ in HaCaT cells (Fig.  9) . 
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Cellular Physiology and Biochemistry mL A-hBD-2 for 6 h, and gene expression was analyzed using RT-PCR. It was found that hBD-2 and A-hBD-2 significantly induced mRNA expression of IL-6, IL-10, TNF-α, and MCP-1 (Fig.  10a) . Since hBD-2 and A-hBD-2 increased the gene expression of chemokines and pro-and anti-inflammatory cytokines, we concluded that they stimulate keratinocytes to produce the corresponding proteins. Following the stimulation of keratinocytes with hBD-2 or A-hBD-2 for 48 h, ELISA kits were used to detect the levels of chemokines and pro-and antiinflammatory cytokines in cell-free supernatants. As shown in Fig. 10b , hBD-2 and A-hBD-2 induced the production of IL-6, IL-10, TNF-α, and MCP-1 from keratinocytes. Furthermore, A-hBD-2 induced greater levels of IL-6, TNF-α, and MCP-1 production than did hBD-2.
A-hBD-2-mediated keratinocytes production of chemokines and cytokines requires PLC activation
Previous studies have found that the PCL-mediated signaling pathway is necessary for the function of hBD-2 on keratinocytes. Therefore, to investigate whether A-hBD-2 activates keratinocytes through the PLC-mediated signaling pathway, HaCaT cells were pretreated with 10 μM U73122 for 2 h before stimulation with 20 μg/mL A-hBD-2. U73122 pretreatment decreased the stimulatory effects of A-hBD-2 on the production of IL-6, IL-10, TNF-α, and MCP-1 (Fig. 10) .
A-hBD-2 promoted wound healing in vivo
Following the application of PBS and hBD-2 or A-hBD-2 to the wound, we investigated the effects of each treatment on wound healing rate. At 3 days after surgery, there were no significant differences in the wound healing rates between the three groups. However, at 5 days after surgery, the hBD-2 and A-hBD-2 groups showed greater wound healing rates compared with the control group (Fig. 11a and 11b ). In addition, epidermal thicknesses in the hBD-2 and A-hBD-2 group also increased compared to the control group (Fig. 11c and  11d ). These results indicated that A-hBD-2 played a positive role in promoting skin wound healing.
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Discussion
In this study, we found that the replacement of GIGDP on the N-terminal of hBD-2 with APKAM, decreases the compound's cytotoxicity in HaCaT cells. Since AMPs have reduced resistance to salt sensitivity, they are potential options for future novel antibiotics, thus we tested whether the designed peptide A-hBD-2 had lower salt sensitivity and stronger structure ability. Our data indicated that A-hBD-2 has stronger anti-S. aureus activity under various concentrations (50 μg/mL, 70 μg/mL, and 100 μg/mL) compared with hBD-2. Natural AMPs lose their antimicrobial activity at physiological salt concentrations, thereby limiting their potential clinical application [16] . Our study found that both hBD-2 and A-hBD-2 had lower antibacterial abilities with increased NaCl concentrations. However, A-hBD-2 had lower salt sensitivity than hBD-2 under higher concentrations of NaCl (50 mM, 70 mM, and 100 mM). These results suggested that A-hBD-2 is more effective for wound healing at the same peptide concentration under the same wound conditions. It is worth noting that the N-terminal peptide was modified and an α-helix structure added, and this may have been important in improving the stability of peptides [17] . Changing the amino acid sequence on the N-and C-terminals of LL-37 decreased its cytotoxicity and enhance its structural stability and antibacterial activity [18] . These modifications augmented the antibacterial activity of peptides, suggesting a template for future peptide synthesis.
When the skin is injured, keratinocytes at the wound edge receive signals to suppress differentiation and promote proliferation and migration in order to enable reepithelialization [19, 20] . During the proliferative phase of wound healing, it is important to promote keratinocyte migration to the wound site; thus, proliferation ability is essential. To achieve this, an ideal drug would promote the migration and proliferation of keratinocytes. Given that previous studies have reported that hBD-2 promotes the migration and proliferation of keratinocytes [8] , we hypothesized that the designer peptide A-hBD-2 would have the same abilities. Our results indicated that A-hBD-2 elicits positive effects on keratinocyte proliferation. In addition to promoting keratinocyte proliferation, hBD-2 also stimulates keratinocyte migration. In the current study, hBD-2 and A-hBD-2 exhibited a stimulatory role in keratinocyte migration in vitro. These results showing that hBD-2 and A-hBD-2 promote keratinocyte proliferation and migration were further supported by our in vivo study because wound closure rate and epidermal thicknesses were increased in the two experimental groups versus the control group. Since HaCaT cells are immortalized, this may impact the proliferation and migration rates that were increased by hBD-2 or A-hBD-2.
The EGFR signaling pathway is important for the growth and survival of epidermal cells. Its activation stimulates cell migration and proliferation in wounds and thus promotes healing [21] . When EGFR protein expression is suppressed, the level of p-STAT3 protein also decreases [22] . Previous studies have shown that the EGFR signaling pathway is involved in hBD-2-induced proliferation and migration of keratinocytes [8] . As A-hBD-2 has a similar structure to hBD-2, we investigated whether the effect of A-hBD-2 on the proliferation and migration of keratinocyte is also similar to hBD-2. A-hBD-2 activated the phosphorylation of EGFR and STAT3 while blocking EGFR or STAT3 significantly inhibited the migration and proliferation of keratinocytes. The mechanism of EGFR activation by A-hBD-2 remains unclear and requires further investigation. Previous studies have reported that EGFR activation could also induce hBDs production from keratinocytes [23] . Thus, it could be suggested that the close interaction between hBDs and EGFR has multiple benefits for wound healing. In the present study, we noticed that the effects of A-hBD-2 on the proliferation and migration of keratinocytes were stronger than those of hBD-2. However, the effects of A-hBD-2 were weaker than the effects of hBD-2 on the phosphorylation of EGFR and STAT3. In our opinion, there are several reasons underlying these results. First, 30 µg/mL A-hBD-2 or 20 µg/mL hBD-2 was the best concentration for keratinocytes. To avoid the effect of dose variation, we used 20 µg/mL in both experimental groups. Second, we detected the effects of A-hBD-2 and hBD-2 on the phosphorylation of EGFR and STAT3 after 20 min. Third, the underlying mechanisms of the proliferation and migration of keratinocytes are complicated and there Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry are several signaling pathways involved in these processes [24, 25] . It seems that A-hBD-2 promotes the proliferation and migration of keratinocytes through other pathways, such as AKT and ERK signaling pathways, and thus needs to be further investigated. The process of re-establishing the barrier function of the skin following injury requires the proliferation of keratinocytes in the basal layer and their differentiation in the upper layers of the epidermis [26] . During the remodeling phase of wound healing, keratinocyte proliferation is followed by differentiation, which is established by a switch from KRT5/ KRT14 in the basal layer to KRT1/KRT10 in suprabasal layers [27, 28] . Higher levels of KRT5/ KRT14 reflect stronger keratinocyte proliferation activity. Our results suggesting that hBD-2 or A-hBD-2 promoted the proliferation of keratinocytes is reflected by increased levels of KRT5/14. During the terminal differentiation of keratinocytes, the levels of loricrin and filaggrin are increased [29] . Previous reports have stated that the S. aureus surface adhesin clumping factor B could have a high-affinity interaction with the cornified envelope protein loricrin, enabling the attachment of bacteria to the anterior nares epithelium [30] . Our data indicated that A-hBD-2 may exhibit its antibacterial effect by reducing the level of loricrin during wound healing. Deficiency in reepithelization is one of the causes of a lack of barrier formation in chronic wounds and diabetic foot ulcers [31] . This may be due to incomplete differentiation of keratinocytes, represented by suppressed differentiation markers such as KRT1/KRT10, filaggrin, and loricrin [32] . As differentiation of keratinocytes is important in the formation of an adequate skin barrier, A-hBD-2 is not recommended for the remodeling stage of wound healing.
A key signaling molecule during epidermal wound repair is Ca 2+ [33] . Recent studies have reported that appropriate drugs, activator protein-1, or exogenous mechanical forces on keratinocytes can accelerate wound healing [34] [35] [36] . Niyonsaba also reported that hBD-2 increases the concentration of intracellular Ca 2+ [8] . In this study, we found that A-hBD-2 had similar effects on promoting the influx of extracellular Ca
2+
. Previous studies have reported that the transient influx of extracellular Ca 2+ occurs through TRPC6 or IP 3 R channels [37, 38] . The TRPC6 activator hyperforin has also been reported to accelerate wound healing through the ATP-Ca 2+ signaling pathway in keratinocytes [39] . In future experiments, we aim to discover the channels and signaling pathways that are involved in the A-hBD-2-induced proliferation and migration of keratinocytes.
In the current study, we observed that both gene and protein expression of pro-and anti-inflammatory cytokines and chemokines such as IL-6, IL-10, TNF-α, and MCP-1 was stimulated by hBD-2 and A-hBD-2 in keratinocytes. Prior studies have reported that, following stimulation by external stresses (such as inflammation, wounding, or oxidative stress), epithelial cells produce multiple AMPs to enhance innate immunity [8, 40] . By adding AMPs directly to the epithelial cells, different cytokines and chemokines produced by keratinocytes modulate the innate immune response. Therefore, the ability of A-hBD-2 to induce proinflammatory cytokine and chemokine production from keratinocytes suggests that A-hBD-2 has immunomodulatory effects on wound healing. In addition, our results indicated that A-hBD-2 enhances the level of the anti-inflammatory cytokine IL-10, which plays a key role in the process of wound healing from the inflammatory phase to the proliferative phase [41] . PLC is a key signaling protein that plays a significant role in multiple physiological processes in cells. Previous studies have reported that AMPs can stimulate the release of cytokines via the activation of PLC signaling and have immunomodulatory effects [5, 42] . The PLC-dependent pathway is involved in the A-hBD-2-induced production of cytokines and chemokines, as demonstrated by the inhibitory effects of U73122 against A-hBD-2 and confirmed by the decreased production of cytokines and chemokines.
Conclusion
In summary, our findings support our previous hypothesis that the designer antimicrobial peptide A-hBD-2 has lower cytotoxicity, stronger structural stability, and Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry higher antimicrobial activity compared to hBD-2. In addition, A-hBD-2 functions in wound healing by stimulating the migration and proliferation of keratinocytes and modulating the immune response. These multiple functions of A-hBD-2 imply that it has potential as a novel drug for wound healing.
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